Annual Drug Patent Expirations for TIVICAY+PD
Tivicay Pd is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
Drug patent litigation for TIVICAY PD.
This drug has one hundred and twenty-four patent family members in thirty-three countries.
The generic ingredient in TIVICAY PD is dolutegravir sodium. One supplier is listed for this compound. Additional details are available on the dolutegravir sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
